381 related articles for article (PubMed ID: 9723996)
1. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
3. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Thibodeaux BA; Traidej M; Austin MS; Marquart ME; Stroman DW; O'Callaghan RJ
Cornea; 2001 Nov; 20(8):878-80. PubMed ID: 11685070
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
11. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Sarayba MA; Shamie N; Reiser BJ; Sweet PM; Taban M; Graff JM; Kesler-Diaz A; Osann KE; McDonnell PJ
J Cataract Refract Surg; 2005 Jul; 31(7):1396-402. PubMed ID: 16105613
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
[TBL] [Abstract][Full Text] [Related]
16. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus corneal virulence in a new topical model of infection.
Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
[TBL] [Abstract][Full Text] [Related]
18. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
Melki SA; Safar A; Yaghouti F; Scharper P; Scharper M; Zeligs B; MacDowell AL; Goldberg MA; Lustbader J
Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):459-62. PubMed ID: 10901479
[TBL] [Abstract][Full Text] [Related]
20. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
